Dilip Shanghvi's journey from the beginning with just Rs 2,000 highlights the importance of resilience, adaptability, and ...

In 2015, the chairman of Sun Pharma Dilip Shanghvi had briefly dethroned Mukesh Ambani to become the country’s richest man. His response to that was, “I am not comfortable.” Though he doesn ...

India's richest pharma magnate's wealth is down by $1.1 billion along with a drop in shares of his Sun Pharmaceutical Industries, the world's fifth-largest generics maker. The company's ...

Anirudha Yerunkar November 12, 2024 4:53 PM IST Dilip Shanghvi's journey from the beginning with just Rs 2,000 highlights the importance of resilience, adaptability, and innovation in achieving ...

Sharing details of Sun Pharma's mergers and acquisitions (M&As) and strategic partnerships, Dilip Shanghvi said, "We are currently in the process of integrating Concert Pharmaceuticals that we ...

But Sun remains India's most valuable drug company (recent market cap: $30.5 billion). Shanghvi personally paid $270 million for a 23% stake in struggling wind-power firm Suzlon Energy in February ...